Market Insights & Analysis from Kramer Capital Research

Archive

Dig Beneath the Uber Debacle and IPOs Still Have the Edge

December 6, 2019

If you think Wall Street’s newest and most dynamic stocks have had a bad year, I forgive you. For every Uber Technologies Inc. (NYSE:UBER) that forced pre-IPO (initial public offering) investors to write down their holdings, there has been a winner making money behind the headlines. After 148 public offerings over the last 49 weeks, […]

Ignore Icahn: Shark Tank Investors Have Mergers On Their Minds

November 29, 2019

Carl Icahn made his fortune cutting up perfectly good companies like TWA, U.S. Steel and even eBay. Now he’s bet $400 million that the entire U.S. mall retail channel is ready for the corporate scrap heap. I think he’s wrong on the mall strategy. While I laid out the logic in last week’s Millionaire Maker […]

What JPMorgan, Morgan Stanley and All Bear Banks Got Wrong

November 22, 2019

Here we are with a handful of trading days left in 2019 and it’s obvious by now that nearly all the high-powered strategists on Wall Street missed the boat on one of the biggest rallies in recent memory. According to JPMorgan, the S&P 500 is poised to fall at least 3 percent by the end […]

The Streaming Wars Have One Clear Winner

November 15, 2019

This wasn’t a great week for several cult favorite stocks. I’ll discuss a few of them in the Cannabis Corner but first, we need to talk about why Netflix Inc. (NASDAQ:NFLX) spent so much of this week on the defensive. Part of the reason is that the Walt Disney Company (NYSE:DIS) launched its streaming video channel, […]

Warren Buffett Missed the Boom of Our Lifetime

November 8, 2019

People revere Warren Buffett as the greatest investor on the planet but even he has big blind spots. For me, one of the biggest is cheerfully buying banks, trains and pipelines while refusing to look at biotech stocks. It’s not like he doesn’t have the money. Berkshire Hathaway Inc. (NYSE:BRK.A) is now sitting on $128 […]

Apple: Still Buying Its Way to Growth 

November 1, 2019

With the market cheering Apple Inc. (NASDAQ:AAPL) this week, it’s hard to recognize this as the company that cast such a chill on Wall Street exactly a year ago. But the only thing that’s really changed here is the share count. Last October, Apple was on the top of the world as the first $1 […]

A Tale Of Two Car Stocks: Tesla Or General Motors?

October 25, 2019

Earnings season is in full swing now and while the numbers are a little better than I was steeled to see, many of the reports still leave a lot to be desired. Let’s start with Tesla Inc. (NASDAQ:TSLA). People on Wall Street are cheering the fact that Elon Musk once again managed to swing the […]

Netflix Has Lost The Streaming Wars

October 18, 2019

Earnings season continues with big wins but Netflix Inc. (NASDAQ:NFLX) is actually down after proving to Wall Street that despite all the recession rumbling, the business hasn’t imploded. It was nice to see that the streaming video market is alive and well. The audience keeps growing. But the company just doesn’t have an easy future here.   Amazon.com […]

Don’t Lock in a Weak Defense When Wall Street Is Scoring Extra Points

October 4, 2019

October can be scary for investors. The biggest challenge of negotiating this season is staying open to the opportunities that lurk behind the shocks. Take this week for example. Reading the headlines, you’d think the economy was in for an unprecedented nightmare ride. People are so bearish that they’re dumping stocks that pay 3 percent […]

Recession? Impeachment? Wall Street Is Ready to Party Like Its 1998

September 27, 2019

Investors have had a whirlwind couple of weeks, starting with the Saudi oil attack and rolling into a formal presidential impeachment inquiry. Add reports of strain in the credit market, a high-stakes Fed meeting, overheated tech stocks and persistent gloom about Treasury yields and the economy, and you’d think the world was ending. But replace […]

Exclusive Report: 3 Biotech Breakthroughs To Bank On
X
Hilary Kramer
Legendary Wall St. trader Hilary Kramer

Where does the Smart Money look for the best biotech stocks? Small- and mid-cap biotechs. They're the ones with the ability to transform the world, and bring investors transformational profits. To get free access to Hilary Kramer's latest report, 3 Biotech Breakthroughs To Bank On, simply tell us where to send it in the box below.

Along with my FREE report, Hilary Kramer's 3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk.
* We value your privacy. You will not be spammed, ever. Period.

Log In

Forgot Password

Search